This story is sponsored by Health Utah. You're fat and tired. It's not insulin's fault. Insulin is just the messenger. When sugar levels are high in the bloodstream, insulin instructs body cells ...

Here we studied the role of Fms-like tyrosine kinase 3 ligand (Flt3L) signalling in the pathogenesis of collagen-induced arthritis (CIA). Methods CIA was induced in mice lacking Flt3L (Flt3L −/−) and ...

The phosphoinositide 3-kinase (PI3K) pathway is a crucial signal transduction system linking the activation of receptor tyrosine kinases (RTKs), G protein-coupled receptors (GPCRs) and oncogenes ...

Types of insulin include rapid-, regular-, intermediate-, and long-acting, based on how long they take to start working. You may take a combination of these when managing type 2 diabetes.

Tyrosine kinase inhibitors (TKIs) have become increasingly important in the treatment of multiple cancers. They basically work by blocking signaling pathways that drive tumor growth in cancer.

The results showed that diabetes technology improved glucose measurement and insulin delivery, enhancing overall diabetes management. Clinical and observational trials showed increased accuracy and ...

Thirty insulin-treated participants with diabetes who drove cars at least three times per week were enrolled and underwent two four-week periods: an alert period using CGM with active low-glucose ...

More information: Roy W. Beck et al, A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes, Diabetes Technology & Therapeutics (2025 ...

State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China ...

Adults with type 2 diabetes using an automated insulin delivery system had greater HbA1c improvements vs. controls. The FDA cleared the use of the Control IQ+ system in adults with type 2 diabetes ...

Background: Tyrosine kinase inhibitors (TKI) in combination with programmed cell death-1 (PD-1) inhibitors become the potential treatment modality for patients undergoing unresectable hepatocellular ...